Variant report

Variant	esv3388599
Chromosome Location	chr14:105399207-105401355
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:18)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:18 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:105362982..105363570-chr14:105399412..105400181,2	MCF-7	breast:
2	chr14:105397847..105399946-chr14:105442912..105445708,2	MCF-7	breast:
3	chr14:105380860..105383186-chr14:105398917..105400427,2	MCF-7	breast:
4	chr14:105399823..105400369-chr14:105511778..105512655,3	MCF-7	breast:
5	chr14:105375706..105377336-chr14:105399096..105400699,2	MCF-7	breast:
6	chr14:105399502..105400009-chr19:33793130..33793745,2	HCT-116	colon:
7	chr14:105399321..105400390-chr14:105511737..105512711,3	K562	blood:
8	chr14:105399113..105400840-chr14:105456852..105459297,2	K562	blood:
9	chr14:105399205..105401135-chr14:105489654..105492411,2	MCF-7	breast:
10	chr14:105398736..105403202-chr14:105431579..105436953,6	MCF-7	breast:
11	chr14:105284508..105286639-chr14:105398983..105401312,2	MCF-7	breast:
12	chr14:105399436..105400309-chr14:105552835..105553556,2	MCF-7	breast:
13	chr14:105398840..105402135-chr14:105423492..105426295,4	MCF-7	breast:
14	chr14:105393329..105396153-chr14:105398779..105401055,3	MCF-7	breast:
15	chr14:105399296..105399819-chr14:105511246..105512107,2	MCF-7	breast:
16	chr14:105397107..105399280-chr14:105419920..105422847,2	MCF-7	breast:
17	chr14:105365193..105367745-chr14:105399799..105401436,2	K562	blood:
18	chr14:105399483..105402053-chr14:105402231..105403735,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000140104	chromatin interactions
ENSG00000230259	chromatin interactions
ENSG00000245848	chromatin interactions
ENSG00000185567	chromatin interactions

Extended variants
information (count: 60 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:60 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs199615700	chr14:105399263-105399264	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs572969155	chr14:105399269-105399270	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs3196340	chr14:105399352-105399353	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs7154387	chr14:105399379-105399380	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs540456840	chr14:105399401-105399402	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs1055853	chr14:105399461-105399462	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs544608095	chr14:105399483-105399484	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs553459548	chr14:105399576-105399577	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs529984796	chr14:105399590-105399591	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs546493458	chr14:105399648-105399649	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs566630134	chr14:105399752-105399753	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs532081100	chr14:105399793-105399794	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs551812991	chr14:105399822-105399823	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs375150568	chr14:105399870-105399871	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs537492567	chr14:105399915-105399916	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs61996025	chr14:105399975-105399976	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs554525850	chr14:105399978-105399979	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs61996026	chr14:105399993-105399994	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs61996027	chr14:105399995-105399996	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs61996028	chr14:105399997-105399998	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs61996029	chr14:105400010-105400011	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs112809524	chr14:105400022-105400023	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs192316673	chr14:105400032-105400033	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs184390485	chr14:105400046-105400047	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs187742552	chr14:105400067-105400068	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs112737045	chr14:105400093-105400094	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs12891816	chr14:105400140-105400141	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs184806471	chr14:105400170-105400171	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs111217130	chr14:105400196-105400197	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs189204199	chr14:105400222-105400223	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs2819418	chr14:105400324-105400325	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs540534282	chr14:105400338-105400339	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs56187104	chr14:105400350-105400351	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs189474505	chr14:105400366-105400367	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs182220262	chr14:105400373-105400374	Bivalent/Poised TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs567901381	chr14:105400464-105400465	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs372006443	chr14:105400487-105400488	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs536919621	chr14:105400488-105400489	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs186009470	chr14:105400534-105400535	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs553313945	chr14:105400550-105400551	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs116999340	chr14:105400579-105400580	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs190911306	chr14:105400612-105400613	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs559134860	chr14:105400672-105400673	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs181361969	chr14:105400694-105400695	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs544308093	chr14:105400695-105400696	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs561300803	chr14:105400713-105400714	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs574665412	chr14:105400723-105400724	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs201260241	chr14:105400806-105400807	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs540473236	chr14:105400810-105400811	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs149496537	chr14:105400911-105400912	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Chronic myeloid leukemia	20724749	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16774939	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Neuroblastoma	18923191	CNVD
Barrett''s syndrome	19417022	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
cataract	16735990	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Cancer	20164920	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Biliary cancer	19435499	CNVD
Follicular lymphoma	20505157	CNVD
Acute lymphoblastic leukemia	20139093	CNVD
Hepatocellular carcinoma	16750200	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Glioblastoma multiforme	21922591	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	22174824	CNVD
Non-small cell lung cancer	18320023	CNVD
Melanoma	17363583	CNVD
Prostate cancer	18632612	CNVD
Congenital heart defect	22367666	CNVD
Developmental delay	22367666	CNVD
Genitourinary abnormalities	22367666	CNVD
Intellectual disability	22367666	CNVD
Microcephaly	22367666	CNVD
Muscularhypotonia	22367666	CNVD
Ocular coloboma	22367666	CNVD
Teratozoospermia	22367666	CNVD
Cervical cancer	21062161	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	21990379	CNVD
Breast cancer	16417655	CNVD
22q11 deletion syndrome	22511897	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Schizophrenia	21399695	CNVD
Intracranial ependymoma	16609018	CNVD
Lung adenocarcinoma	17086460	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
14q deletion syndrome	22511897	CNVD
Epilepsy	22083797	CNVD
Urothelial carcinoma	21177765	CNVD
Ovarian cancer	21720365	CNVD
Cancer	17440070	CNVD
Neurocytoma	17123091	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Central neurocytomas	17123091	CNVD
Acute lymphoblastic leukemia	17315016	CNVD
Lung cancer	17086460	CNVD
Mortal	21835882	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	17426248	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Schizophrenia	20967226	CNVD
early-passage human iPS cells	21368824	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	23813976	CNVD
lymphocytic leukemia	21291569	CNVD
Cancer	20164919	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:307 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:105397800-105399800	Active TSS	Rectal Smooth Muscle	rectum
2	chr14:105398200-105399600	Bivalent Enhancer	Fetal Brain Male	brain
3	chr14:105398200-105399600	Enhancers	Spleen	Spleen
4	chr14:105398200-105399800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
5	chr14:105398200-105399800	Enhancers	Fetal Heart	heart
6	chr14:105398400-105399400	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr14:105398400-105399400	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
8	chr14:105398400-105399400	Flanking Active TSS	Stomach Smooth Muscle	stomach
9	chr14:105398400-105399600	Flanking Bivalent TSS/Enh	Fetal Stomach	stomach
10	chr14:105398400-105399800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
11	chr14:105398400-105399800	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
12	chr14:105398400-105399800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
13	chr14:105398400-105399800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
14	chr14:105398400-105400000	Bivalent/Poised TSS	Osteobl	bone
15	chr14:105398400-105400800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
16	chr14:105398600-105399400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr14:105398800-105399400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
18	chr14:105398800-105399400	Bivalent Enhancer	Fetal Lung	lung
19	chr14:105398800-105399600	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr14:105398800-105399600	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr14:105398800-105399600	Flanking Active TSS	Adipose Nuclei	Adipose
22	chr14:105398800-105399600	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
23	chr14:105398800-105399800	Bivalent/Poised TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr14:105398800-105399800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
25	chr14:105398800-105399800	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
26	chr14:105398800-105399800	Active TSS	Colon Smooth Muscle	Colon
27	chr14:105398800-105399800	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
28	chr14:105398800-105400600	Enhancers	Primary B cells from peripheral blood	blood
29	chr14:105398800-105400800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
30	chr14:105398800-105400800	Active TSS	Brain Angular Gyrus	brain
31	chr14:105399000-105399400	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
32	chr14:105399000-105399400	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
33	chr14:105399000-105399400	Enhancers	Primary monocytes fromperipheralblood	blood
34	chr14:105399000-105399400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
35	chr14:105399000-105399400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
36	chr14:105399000-105399400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
37	chr14:105399000-105399400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr14:105399000-105399400	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
39	chr14:105399000-105399400	Enhancers	Liver	Liver
40	chr14:105399000-105399400	Flanking Active TSS	Brain Anterior Caudate	brain
41	chr14:105399000-105399400	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
42	chr14:105399000-105399400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
43	chr14:105399000-105399400	Bivalent Enhancer	Fetal Thymus	thymus
44	chr14:105399000-105399400	Active TSS	Ovary	ovary
45	chr14:105399000-105399400	Bivalent/Poised TSS	Psoas Muscle	Psoas
46	chr14:105399000-105399600	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr14:105399000-105399600	Flanking Bivalent TSS/Enh	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr14:105399000-105399600	Transcr. at gene 5' and 3'	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr14:105399000-105399600	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
50	chr14:105399000-105399600	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links